Throughout life, our cells are constantly exposed to environmental and internal factors that can damage DNA. While such DNA ...

NX-1607 demonstrated on-target peripheral immune activation characteristic of an active immune-oncology agent with a novel immune checkpoint ...

NX-1607 demonstrated on-target peripheral immune activation characteristic of an active immune-oncology agent with a novel immune checkpoint mechanism distinct from PD-1/PD-L1 therapies ...

An mRNA cancer vaccine carries its own immune booster and lights up when it starts working, showing treatment success in mice ...

A review of recent literature shows bioengineering is reshaping oncology, from synthetic biology to nanomedicine, but what's ...

Researchers found that microplastics from everyday plastic tableware accumulate in human semen and, although not linked to ...

Presentations highlight HCB101's differentiated profile and introduce first preclinical data from HCB301, underscoring HanchorBio's innovation in next-generation immunotherapies ...

The 2025 ESMO annual meeting featured a metastatic castration-resistant prostate cancer (mCRPC) session and a presentation by ...

LEO Pharma A/S, a global leader in medical dermatology, is advancing the understanding of skin disease and its impact on patients' lives with the presentation of 46 abstracts at the upcoming 2025 Fall ...

Researchers say they have developed a novel ‘nanoparticle-based’ jab that can prevent melanoma, pancreatic and ...

Researchers have developed a nanoparticle vaccine that prevented melanoma, pancreatic and triple-negative breast cancer in ...